Effects of breakthrough infections on clinical characteristics and outcomes among patients with Japanese encephalitis - 06/09/23
Doi : 10.1016/j.jinf.2023.07.012
Yiguo Zhou 1
Global Center for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China
Ling-Lu Zhao 2
Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou Province, China
Wan-Xue Zhang
Global Center for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
Su-Ye Zhao
Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou Province, China
Chao Wang
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
Juan Du
Global Center for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
Ting-Ting Wei
Global Center for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
Ya-Qiong Liu
Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing, China
Qing-Bin Lu ⁎ 
Global Center for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing, China
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China
∗Correspondence to: Department of Laboratorial of Science and Technology & Vaccine Research Center, School of Public Health, Peking University, No. 38 Xue-Yuan Road, Haidian District, Beijing 100191, China.Department of Laboratorial of Science and Technology & Vaccine Research Center, School of Public Health, Peking UniversityNo. 38 Xue-Yuan Road, Haidian DistrictBeijing100191China
Ming Liu ⁎
Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou Province, China
**Correspondence to: Institute for Immunization Program, Guizhou Provincial Center for Disease Control and Prevention, No. 73, Bageyan Road, Guiyang 550004, China.Institute for Immunization Program, Guizhou Provincial Center for Disease Control and PreventionNo. 73, Bageyan RoadGuiyang550004China
Fuqiang Cui ⁎
Global Center for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China
Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing, China
Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China
***Correspondence to: Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, 38th Xueyuan Road, Haidian District, Beijing 100191, China.Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University38th Xueyuan Road, Haidian DistrictBeijing100191China
Le texte complet de cet article est disponible en PDF.
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 4
P. 350-353 - octobre 2023 Retour au numéro
Article précédent
- SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
- Kristin G.-I. Mohn, Geir Bredholt, Therese Bredholt Onyango, Karl A. Brokstad, Fan Zhou, Jan Cato Holter, Kristian Tonby, Anne Ma Dyrhol-Riise, Rebecca Jane Cox, Bergen COVID-19 Research Group, Norwegian SARS-CoV-2 Study Group
- Investigation of escape mechanisms of SARS-CoV-2 Omicron sub-lineages and exploration of potential antibodies for XBB.1
- Bo Sun, Feng Gao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?